Recently, new immune-based treatments have shown impressive results when multiple myeloma returns, changing how doctors treat ...

Explore the vital role of bone marrow stem cells. Learn how they drive bone remodeling, immunity, and skeletal health in this ...

The map was developed by using single-cell RNA sequencing to analyze 1.4 million plasma and immune cells in bone marrow from over 300 patients.

The results build on evidence U.S. regulators found so compelling last year they proactively awarded J&J a new kind of drug review voucher.

A new research perspective was published in Oncotarget's Volume 15 on January 16, 2024, entitled, "Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma." Multiple ...

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...

New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing right way for myeloma care.

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients. These ...

Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...

ShardaCare-Healthcity has launched a state-of-the-art Institute of Bone Marrow Transplant to treat complex blood disorders in both children and adults, featuring advanced therapies and a focus on ...

The latest approval marks the twelfth indication for Darzalex Faspro and fifth in newly diagnosed multiple myeloma. ・The ...